New Drug Trials for Multiple Sclerosis

A repair drug for multiple sclerosis just cleared its

third trial in a row.

Here's the catch: nobody is celebrating.

Metformin, the diabetes drug, combined with

clemastine, an antihistamine, helps the brain

rebuild the protective coating around nerves that

multiple sclerosis destroys.

This isn't the first time it's worked.

It's the third separate trial now showing this combination

significantly increases myelin repair in people

with relapsing remitting multiple sclerosis.

But here's the honest part.

After six months of treatment, patients showed no

improvement on disability or vision.

The repair is measurably real. The benefit patients

can actually feel isn't there yet.

Now,

that's not necessarily bad news. It might just mean six months

is too short.

The lead researcher on this trial says it could take years for real

myelin repair to translate into less

disability, even if the underlying biology is working

exactly as hoped.

Would you take a drug proven to physically repair damage in your brain,

knowing you might not feel the benefit for years?

Or does "no improvement yet" change how you'd weigh

it? And don't forget, metformin and clemastine is the

easiest and cheapest drug combination that a person can

get.